1 citations
,
September 2025 in “EMJ Dermatology” Menopause affects skin and hair, and more research is needed for effective treatments.
1 citations
,
May 2025 in “Maturitas” This article highlights that hormonal changes during menopause can significantly affect hair health, leading to decreased hair density, altered texture, and increased hair disorders, which may subsequently impact emotional well-being in women.
1 citations
,
February 2025 in “Journal of Endocrinological Investigation” This review discusses the prevalence and clinical impact of menstrual abnormalities, acne, and hirsutism in young women with Cushing's syndrome and reports no new clinical results.
1 citations
,
August 2024 in “Skin Research and Technology” This study found no significant causal relationship between androgenetic alopecia and serum uric acid levels using various Mendelian randomization methods, suggesting the need for future research with larger cohorts and advanced methods to further explore this potential association.
1 citations
,
February 2024 in “Aesthetic Surgery Journal” This study found that laser hair removal results in females were not influenced by hormonal fluctuations during different menstrual cycle phases, although pain tolerance was slightly lower during menstruation without reaching statistical significance.
1 citations
,
January 2023 in “Nutrients” This study found that high consumption of sugar-sweetened beverages is associated with an increased risk of male pattern hair loss among young men in mainland China.
1 citations
,
January 2020 in “Bioscience Reports” This study found that prolonged use of finasteride in women led to altered levels of sex steroids, DNA damage, and increased menstrual bleeding, suggesting adverse health effects without clear benefits for androgenetic alopecia treatment.
1 citations
,
January 2018 in “BMJ” This abstract highlights that Hickey and colleagues provided an overview of non-hormonal treatments for menopausal symptoms but missed discussing female pattern hair loss (FPHL), a common issue during menopause.
1 citations
,
December 2025 in “American Journal of Clinical Dermatology” This source emphasizes that menopause affects the onset and course of certain skin conditions, urging dermatologists to consider menopausal status and hormone therapy when treating skin diseases, while also calling for more diverse, dermatology-focused research to improve personalized care.
1 citations
,
June 2025 in “The Journal of Dermatology” This study demonstrated that individuals with alopecia areata in Japan experience significant stigma and mental health issues, with perceived stigma and dissatisfaction with hair growth negatively correlated with disease severity.
1 citations
,
November 2023 In this study, researchers implemented a recommendation algorithm using Melia dubia liquid and fermented rice water to improve nutritional suggestions for women experiencing menstrual issues, achieving an accuracy of 94% in detecting nutritional needs during menstrual cycles.
1 citations
,
November 2023 in “Biomedicines” In this article, researchers link menopause to hair follicle lifecycle changes, noting that estrogen decline, metabolic shifts, genetics, and stress can contribute to hair thinning and texture variation, although effects differ among women.
1 citations
,
July 2022 in “Clinical and Experimental Dermatology” This review reports that menopause affects hair cycle regulation and is associated with conditions like female pattern hair loss, but further research is needed to explore hormonal therapy as a treatment option.
1 citations
,
March 2022 in “medRxiv (Cold Spring Harbor Laboratory)” This study found that women with PCOS have a significant risk of mental health disorders, including depression and anxiety, but results varied due to methodological differences, and ethnic disparities were not well-examined.
1 citations
,
November 2021 in “Lara D. Veeken” This article discusses the interaction between menopause and rheumatic diseases, emphasizing the need for rheumatologists to recognize menopausal symptoms and consider hormone replacement therapy in patient care, but it provides no new experimental results.
1 citations
,
June 2021 in “Case reports in gastrointestinal medicine” In this case study, a man's hair and nail symptoms, following dental treatments, resolved with mesalazine therapy after investigating suspected clindamycin allergy and diagnosing mucosal changes.
1 citations
,
June 2019 in “Current Developments in Nutrition” This study found that after 12 weeks of taking 10 mg of S-equol daily, over 90% of participating perimenopausal and menopausal women reported improvements in symptoms like hot flashes, night sweats, and sleep disturbances.
January 2026 in “Sleep Medicine” Men with hair loss are more likely to have cholesterol issues and sleep apnea.
January 2026 in “Arhiv za farmaciju” This paper reviews the evidence connecting androgen deficiency to skin ageing in men, emphasizing that reduced testosterone exacerbates ageing signs like epidermal thinning and decreased elasticity and advocates for tailored skincare and aesthetics for this demographic.
This study found that nearly 20% of men surveyed in German-speaking Europe had undergone cosmetic surgery, with higher conformity to traditional masculinity ideologies linked to greater odds of having these procedures, particularly hair transplants.
February 2021 in “International journal of men's social and community health” This study found that participants perceived bald men more negatively based on facial expressions and reported varied body dissatisfaction, which was weakly linked to wellbeing and muscularity behaviors.
Men need essential vitamins like D, B Complex, and A for health, and should consult doctors for personalized advice.
August 2012 in “Expert Review of Dermatology” Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.
August 2007 in “Pajoohandeh Journal” Men with baldness may have a higher risk of heart disease.
February 1999 in “Drugs in R & D” The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.
March 2026 in “Menopause The Journal of The North American Menopause Society” This research highlights that migraine in midlife women, during perimenopause, often becomes more frequent and intense, with evolving characteristics like migraine aura, and is associated with increased stroke risk, especially with hormone therapies.
January 2026 in “Medicine” This study found that elevated LDL-C levels increased the risk of developing androgenic alopecia, whereas HDL-C levels showed no significant effect.
December 2025 in “Journal of Cosmetic Dermatology” This study found that finasteride use is not significantly associated with an increased risk of depression or suicide, based on Mendelian randomization analysis and COX regression analysis in a large UK Biobank cohort.
November 2025 in “Frontiers in Pharmacology” This mini-review examines ethnopharmacological approaches to manage hair loss in postmenopausal women, highlighting promising botanical remedies like saw palmetto, rosemary oil, and ginseng. The authors underscore a need for more interdisciplinary trials and focus on traditional remedies' multifaceted benefits, while noting gaps in menopausal-specific evidence.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” This study found that specific immune cell phenotypes, particularly CD25 on CD4 Treg cells, were causally linked to androgenic alopecia, suggesting potential targets for immune-based therapies.